What is the price-to-earnings ratio of Eisai Co?
The price-earnings ratio of Eisai Co is currently 2.64.
Eisai Co P/S 2024
Eisai Co P/S
2.64
Ticker
4523.T
ISIN
JP3160400002
WKN
855526
As of Nov 3, 2024, Eisai Co's P/S ratio stood at 2.64, a -24.36% change from the 3.49 P/S ratio recorded in the previous year.
The Eisai Co P/S history
Eisai Co Aktienanalyse
What does Eisai Co do?
Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Eisai Co's P/S Ratio
Eisai Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Eisai Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Eisai Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Eisai Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Eisai Co stock
How has the price-earnings ratio of Eisai Co changed compared to last year?
The price-to-earnings ratio of Eisai Co has increased by -24.36% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Eisai Co high compared to other companies?
Yes, the price-to-earnings ratio of Eisai Co is high compared to other companies.
How does an increase in the price-earnings ratio of Eisai Co affect the company?
An increase in the price-earnings ratio of Eisai Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Eisai Co affect the company?
A decrease in the price-earnings ratio of Eisai Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Eisai Co?
Some factors that influence the price-earnings ratio of Eisai Co are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Eisai Co pay?
Over the past 12 months, Eisai Co paid a dividend of 160 JPY . This corresponds to a dividend yield of about 3.15 %. For the coming 12 months, Eisai Co is expected to pay a dividend of 160.96 JPY.
What is the dividend yield of Eisai Co?
The current dividend yield of Eisai Co is 3.15 %.
When does Eisai Co pay dividends?
Eisai Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Eisai Co?
Eisai Co paid dividends every year for the past 23 years.
What is the dividend of Eisai Co?
For the upcoming 12 months, dividends amounting to 160.96 JPY are expected. This corresponds to a dividend yield of 3.17 %.
In which sector is Eisai Co located?
Eisai Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Eisai Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Eisai Co from 12/1/2024 amounting to 80 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Eisai Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Eisai Co in the year 2023?
In the year 2023, Eisai Co distributed 160 JPY as dividends.
In which currency does Eisai Co pay out the dividend?
The dividends of Eisai Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Eisai Co
Our stock analysis for Eisai Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eisai Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
